Article
Genetic polymorphism of the OPG gene associated with breast cancer.
BMC cancer - 31 Jan 2013
Ney Jasmin Teresa, Juhasz-Boess Ingolf, Gruenhage Frank, Graeber Stefan, Bohle Rainer Maria, Pfreundschuh Michael, Solomayer Erich Franz, Assmann Gunter
Abstract excerpt
BACKGROUND: The receptor activator of NF-κB (RANK), its ligand (RANKL) and osteoprotegerin (OPG) have been reported to play a role in the pathophysiological bone turnover and in the pathogenesis of breast cancer. Based on this we investigated the role of single nucleotide polymorphisms (SNPs) within RANK, RANKL and OPG and their possible association to breast cancer risk. METHODS: Genomic DNA was obtained from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
